(Q34216605)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22467778%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

title

The Fagerström Test for Nicotine Dependence as a predictor of smoking abstinence: a pooled analysis of varenicline clinical trial data (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22467778%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

0 references

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22467778%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

author name string

Karl Fagerström

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22467778%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Cristina Russ

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22467778%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Ching-Ray Yu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22467778%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Carla Yunis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22467778%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

publication date

30 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22467778%20AND%20SRC:MED&resulttype=core&format=json

Nicotine and Tobacco Research

27 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22467778%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22467778%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22467778%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

1467-1473

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22467778%20AND%20SRC:MED&resulttype=core&format=json

Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial

27 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTS018

DSM criteria for tobacco use disorder and tobacco withdrawal: a critique and proposed revisions for DSM-5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTS018

Time to first cigarette in the morning as an index of ability to quit smoking: implications for nicotine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTS018

Effects of varenicline in adult smokers: a multinational, 24-week, randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTS018

Predicting smoking cessation and major depression in nicotine-dependent smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTS018

Commentary on Baker et al. (2012): Assessing dependence-are specific criteria for nicotine enough or do we need to consider its forms of administration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTS018

A comparison of the Fagerström Test for Nicotine Dependence and smoking prevalence across countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTS018

Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTS018

Strength of urges to smoke as a measure of severity of cigarette dependence: comparison with the Fagerström Test for Nicotine Dependence and its components.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTS018

A double-blind randomized placebo-controlled pilot study of neuropsychiatric adverse events in abstinent smokers treated with varenicline or placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTS018

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTS018

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTS018

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTS018

Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTS018

Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTS018

Treating heavy smokers in primary care with the nicotine nasal spray: randomized placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTS018

Randomised controlled trial of nasal nicotine spray in smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTS018

Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTS018

Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTS018

A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTS018

Varenicline for smoking cessation: a placebo-controlled, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTS018